NCT07060716 - Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monitoring | Biotech Hunter

Enrollment

125

Participants

Timeline

Start Date

September 8, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions

Kidney Transplant RejectionCell-free DNA

Interventions

DIAGNOSTIC_TEST

donor-derived cell-free DNA test

A donor-derived cell-free DNA (dd-cfDNA) test used to measure the concentration of total cell-free DNA and the fractional abundance of the dd-cfDNA.

Trial Locations (10)

ACTIVE_NOT_RECRUITING

Charite Universitatsmedizin, Berlin

ACTIVE_NOT_RECRUITING

University of Pittsburgh Medical Center, Pittsburgh

ACTIVE_NOT_RECRUITING

Mayo Clinic in Florida, Jacksonville

RECRUITING

Tampa General Hospital, Tampa

RECRUITING

Vanderbilt University Medical Center, Nashville

ACTIVE_NOT_RECRUITING

Cleveland Clinic, Cleveland

ACTIVE_NOT_RECRUITING

Institute of Immunology - Transplantation Immunology, Heidelberg

ACTIVE_NOT_RECRUITING

Baylor, Scott & White Research Institute, Dallas

RECRUITING

Intermountain Health, Murray

ACTIVE_NOT_RECRUITING

University of Southern California Keck School of Medicine, Los Angeles